Related Experiment Video
Updated: Aug 10, 2026

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers
Published on: March 8, 2012
Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1
Lisa J Matthias1, Patricia T W Yam, Xing-Mai Jiang
1Centre for Thrombosis and Vascular Research, School of Medical Sciences, University of New South Wales and Department of Haematology, Prince of Wales Hospital, Sydney, NSW 2052, Australia.
Insights
Redox changes in the CD4 D2 domain, regulated by thioredoxin, are crucial for HIV-1 entry. Targeting these redox states offers a novel strategy for developing HIV-1 entry inhibitors.
Area of Science:
- Immunology
- Virology
- Biochemistry
Background:
- CD4 is a key receptor for HIV-1 entry, mediating cell-cell interactions in the immune system.
- The extracellular region of CD4 comprises four immunoglobulin-like domains (D1-D4), with disulfide bonds in D1, D2, and D4.
Purpose of the Study:
- To investigate the role of redox activity in CD4 domains, specifically the D2 disulfide bond, concerning HIV-1 entry.
- To identify potential targets for novel HIV-1 entry inhibitors.
Main Methods:
- Analysis of the redox activity of the CD4 D2 disulfide bond.
- Investigating the regulation of CD4 redox state by thioredoxin secreted from CD4(+) T cells.
- Utilizing a hydrophilic trivalent arsenical to lock CD4 and thioredoxin dithiols in a reduced state.
Main Results:
- The disulfide bond in the D2 domain of CD4 was found to be redox-active.
- Thioredoxin, secreted by CD4(+) T cells, regulates the redox state of CD4.
- Inhibiting the reduced dithiol state of CD4 D2 with an arsenical compound blocked HIV-1 entry into cells.
Conclusions:
- Redox modifications in the CD4 D2 domain are critical for HIV-1 viral entry.
- The CD4 D2 redox state represents a new therapeutic target for developing inhibitors of HIV-1 entry.
Abstract:
CD4, a member of the immunoglobulin superfamily of receptors that mediates cell-cell interactions in the immune system, is the primary receptor for HIV-1. The extracellular portion of CD4 is a concatenation of four immunoglobulin-like domains, D1 to D4. The D1, D2 and D4 domains each contain a disulfide bond. We show here that the D2 disulfide bond is redox-active. The redox state of the thiols (disulfide versus dithiol) appeared to be regulated by thioredoxin, which is secreted by CD4(+) T cells. Locking the CD4 and the thioredoxin active-site dithiols in the reduced state with a hydrophilic trivalent arsenical blocked entry of HIV-1 into susceptible cells. These findings indicate that redox changes in CD4 D2 are important for HIV-1 entry and represent a new target for HIV-1 entry inhibitors.
More Related Videos
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Size and Structure of Viral Genomes
Inhibitors of Virion Maturation and Assembly

